Financial Results Announcement - Bio-Path Holdings, Inc. announced financial results for the year ended December 31, 2024, on March 28, 2025[5]. - The press release detailing the financial results is attached as Exhibit 99.1[5]. - The report does not include specific financial metrics or performance indicators in the provided content[4]. - The financial results announcement does not specify any new product developments or market expansions[5]. - There is no mention of user data or future guidance in the provided content[5]. Regulatory Compliance - The company is not classified as an emerging growth company under the Securities Act of 1933[3]. - The report is filed under the Securities Exchange Act of 1934, indicating compliance with regulatory requirements[4]. Company Information - The company’s principal executive offices are located at 4710 Bellaire Boulevard, Suite 210, Bellaire, Texas[2]. - The company’s trading symbol is BPTH, and it is registered under the Commission File Number 001-36333[2]. - The report was signed by Peter H. Nielsen, President and CEO, on the date of the announcement[10].
Bio-Path(BPTH) - 2024 Q4 - Annual Results